Biocon Biologics secures FDA approval for Yesafili, an interchangeable biosimilar to Eylea, for ophthalmological conditions. Launch in Canada set.

Related Keywords

United States , Canada , United Kingdom , Shreehas Tambe , Biocon Biologics , Twitter , Biocon Ltd , Biocon , Biocon Biologics Ltd , Facebook , Linkedin ,